Skip to main content
. 2021 Jul 5;48(2):164. doi: 10.3892/ijmm.2021.4996

Figure 1.

Figure 1

Effect of AS-IV on body weight, FBG and serum lipid profiles in different groups after 12 weeks of administration. (A) Weight, (B) FBG, (C) TC, (D) TG, (E) LDL-C, and (F) HDL-C. Data are presented as the mean ± standard deviation (n=7-10). ***P<0.001 vs. WT control; #P<0.05 and ##P<0.01 vs. db/db + vehicle; and &P<0.05 and &&P<0.01 vs. db/db + benazepril. AS-IV, astragaloside IV; WT, wild-type mice; FBG, fasting blood glucose; TC, total cholesterol; TG, triacylglycerol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.